Applications of Functionalized Fullerenes in Tumor Theranostics
Authors:
- Lijing MaLMLijing Ma
- Ying LiuYLYing Liu
- Chunying ChenCCChunying Chen
Open Access
- 1 January 2012
- journal article
- Published by Ivyspring International Publisher in Theranostics
- Vol. 2 (3) , 238-250
Abstract
Functionalized fullerenes with specific physicochemical properties have been developed for cancer diagnosis and therapy. Notably, metallofullerene is a new class of magnetic resonance imaging (MRI) contrast-enhancing agent, and may have promising applications for clinical diagnosis. Polyhydroxylated and carboxyl fullerenes have been applied to photoacoustic imaging. Moreover, in recent years, functionalized fullerenes have shown potential in tumor therapies, such as photodynamic therapy, photothermal treatment, radiotherapy and chemotherapeutics. Their antitumor effects may be associated with the modulation of oxidative stress, anti-angiogenesis, and immunostimulatory activity. While various types of novel nanoparticle agents have been exploited in tumor theranostics, their distribution, metabolism and toxicity in organisms have also been a source of concern among researchers. The present review summarizes the potential of fullerenes as tumor theranostics agents and their possible underlying mechanisms are discussed.Keywords
This publication has 71 references indexed in Scilit:
- The inhibition of death receptor mediated apoptosis through lysosome stabilization following internalization of carboxyfullerene nanoparticlesBiomaterials, 2011
- C60(Nd) nanoparticles enhance chemotherapeutic susceptibility of cancer cells by modulation of autophagyNanotechnology, 2010
- Immunostimulatory properties and enhanced TNF- α mediated cellular immunity for tumor therapy by C60(OH)20nanoparticlesNanotechnology, 2009
- Inhibition of Tumor Growth by Endohedral Metallofullerenol Nanoparticles Optimized as Reactive Oxygen Species ScavengerMolecular Pharmacology, 2008
- 212Pb@C60and Its Water-Soluble Derivatives: Synthesis, Stability, and Suitability for RadioimmunotherapyJournal of the American Chemical Society, 2007
- Pharmacological Studies on Fullerene (C60), a Novel Carbon Allotrope, and Its DerivativesJournal of Pharmacological Sciences, 2006
- Multihydroxylated [Gd@C82(OH)22]n Nanoparticles: Antineoplastic Activity of High Efficiency and Low ToxicityNano Letters, 2005
- In vivo inhibition of tumor angiogenesis by a soluble VEGFR-2 fragmentExperimental and Molecular Pathology, 2004
- In vivo studies of fullerene-based materials using endohedral metallofullerene radiotracersProceedings of the National Academy of Sciences, 1999
- In vivo biological behavior of a water-miscible fullerene: 14C labeling, absorption, distribution, excretion and acute toxicityChemistry & Biology, 1995